Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
5000 participants
OBSERVATIONAL
2020-01-08
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intracardiac Flow Assessment in Cardiac Amyloidosis
NCT05379101
Observational Epidemiological Study of Patients Suffering From Systemic Amyloidosis
NCT06866912
International Cardiac Amyloidosis Registry
NCT06894290
Prevalence of Amyloidosis in Heart Failure (PREVAMIC)
NCT04066452
Identification of Prognostic Parameters in Patients With " Senile " Amyloid Cardiomyopathy
NCT04225754
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This registry is an observational, multi-center study designed to collect data and analyze it retrospectively on patients with cardiac amyloidosis who have been evaluated and treated at major amyloid centers across the US and internationally between 1997 and 2025. It is expected that the total patient population will be approximately 5000 patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AL and TTR amyloidosis
immunoglobulin light chain amyloidosis (AL) and transthyretin amyloidosis (ATTR)
Registry
Observational, data collection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Registry
Observational, data collection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Specific to CSMC: If the individual provided consent while they were alive, and if sufficient information exists in their chart, their data will be included.
* Information on deceased individuals may be included, but only with the appropriate approval from the external site IRB and/or according to the federal regulations for the protection of human subjects.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cedars-Sinai Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jignesh Patel, MD, PhD
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Arizona Sarver Heart Center
Tucson, Arizona, United States
UC San Diego Health, Sulpizio Cardiovascular Center
La Jolla, California, United States
Scripps Health
La Jolla, California, United States
University of California Davis
Sacramento, California, United States
University of California, San Francisco
San Francisco, California, United States
MedStar Health and Vascular Institute/Georgetown University School of Medicine
Washington D.C., District of Columbia, United States
Johns Hopkins University School of Medicine
Baltimore, Maryland, United States
Tufts Medical Center
Boston, Massachusetts, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Boston Medical Center
Boston, Massachusetts, United States
Saint Luke's Hospital of Kansas City
Kansas City, Missouri, United States
Washington University in St. Louis
St Louis, Missouri, United States
NYU Langone Health
New York, New York, United States
Weill Cornell Medicine
New York, New York, United States
The Mount Sinai Hospital
New York, New York, United States
Columbia University Irving Medical Center, Clinical Cardiovascular Research Laboratory for the Elderly (CUMC/CCRLE)
New York, New York, United States
Duke Health
Durham, North Carolina, United States
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania, United States
Medical University of South Carolina
Charleston, South Carolina, United States
University of Texas Southwestern Medical Center
Dallas, Texas, United States
University of Texas Health Science Center at Houston
Houston, Texas, United States
University of Utah
Salt Lake City, Utah, United States
University of Calgary
Calgary, Alberta, Canada
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00000442
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.